FedInvent™ Patent Applications

New Taxpayer Funded Applications for Thursday, June 09, 2022 

This page was updated on Friday, June 10, 2022 at 05:18 PM GMT

FedInvent analyzed 167 taxpayer funded patent applications this week.

On Thursday, June 9, 2022, the U.S. Patent and Trademark Office (USPTO) published 8,345 pre-grant patent applications. One hundred sixty-seven (167) of these patents benefitted from taxpayer funding. Here is how they break down .

  • One hundred sixty-four (164) patents have Government Interest Statements.
  • Twenty (20) have a government agency as an applicant or an assignee.
  • A federal department is the only assignee on eight (8) patent applications.
  • The 167 new patents have 196 department-level funding citations.
  • These patent applications are the work of 576 inventors.
  • The 552 American inventors come from 35 states and the District of Columbia.
  • The 24 foreign inventors come from 11 countries.  This week there is an inventor from Macau and three (3) from Russia.
  • There are 128 patent applicationss (77%) where at least one assignee or the inventors are from a college or university, the HERD.
  • Federally Funded Research and Development Centers (FFRDCs) received eight (8) patent applications.
  • One (1) patent applications were assigned Y CPC symbols indicating that the invention may be useful in mitigating the impact of climate change.
  • There are no Bayh-Dole scofflaws this week.

The Big Three States

This week's top three states are:

  1. California has 34 first-named inventors and 101 total inventors.
  2. Massachusetts has 18 first-named inventors and 73 total inventors.
  3. New York has 11 first-named inventors and 42 total inventors.

This week six states — California, Massachusetts, New York, Pennsylvania, Florida, Maryland — account for more than half of the inventors.

Learn More About Taxpayer Funded Patents Here

The List of This Week's Patent Applications

Just a list — patent application publication number with a link and the title, for those patentistas who like to browse.

About The Icons On the List Below

  • The icon takes you to the full text version of the patent application at USPTO;
  • The icon takes you to the PDF version of the patent application at USPTO; and
  • The icon takes you to the details about the patent on the FedInvent Details page.
  • When you use the icon the patent you are interested appears at the top of the list on the details page.
Patent Application Title
001 20220174962
 
ENZYME-LOADED POLLEN-MIMICKING MICROPARTICLES FOR ORGANOPHOSPHATE DETOXIFICATION OF INSECT POLLINATORS 
002 20220174963
 
COMPOSITIONS AND METHODS RELATING TO INSECTICIDES 
003 20220175006
 
FASTING MIMICKING KETOGENIC DIET (FMD) TO PROMOTE SKELETAL MUSCLE REGENERATION AND STRENGTH 
004 20220175007
 
FASTING MIMICKING KETOGENIC DIET TO IMPROVE IMMUNE FUNCTION AND VACCINE RESPONSE AND MINIMIZE RISK IN ADULTS AND ELDERLY 
005 20220175253
 
REVERSIBLY SWITCHABLE PHOTOACOUSTIC IMAGING SYSTEMS AND METHODS 
006 20220175254
 
NEAR-FIELD COHERENT SENSING METHODS AND SYSTEMS 
007 20220175285
 
TRANSLATIONAL METHOD TO DETERMINE BIOLOGICAL BASIS FOR DYSLEXIA 
008 20220175306
 
NEUROMODULATION TO TARGET GLUCOSE TRANSPORTER AND/OR INCRETIN PATHWAYS 
009 20220175341
 
Device, System, and Method For Hemispheric Breast Imaging 
010 20220175413
 
APPARATUSES, SYSTEMS AND METHODS FOR PERFORATING AND ASPIRATING INNER EAR 
011 20220175510
 
BIOMEDICAL PATCHES WITH ALIGNED FIBERS 
012 20220175560
 
Harness For Coupling To An Upper Arm Prosthesis, And Systems And Methods Of Making And Using Same 
013 20220175661
 
SYNERGIST THERAPY FOR ENHANCED DRUG DELIVERY: MAGNETIC FIELD FACILITATED NANOPARTICLE MICROPORATION 
014 20220175675
 
ENCAPSULATING MOLECULES IN FAT GLOBULES 
015 20220175681
 
SELF-RIGHTING ARTICLES 
016 20220175687
 
NANOPARTICLES FOR DRUG DELIVERY TO BRAIN 
017 20220175700
 
VISUAL CYCLE MODULATORS 
018 20220175704
 
SENSITIZATION OF CANCER CELLS TO DIFFERENTIATION THERAPY WITH MITOCHONDRIAL UNCOUPLER NICLOSAMIDE ETHANOLAMINE 
019 20220175705
 
DISULFIDE-MASKED PRO-CHELATOR COMPOSITIONS AND METHODS OF USE 
020 20220175722
 
DEGRADERS OF FIBROBLAST GROWTH FACTOR RECEPTOR 2 (FGFR2) 
021 20220175730
 
Effects of Age-Dependent Changes in Cell Size on Endothelial Cell Growth 
022 20220175736
 
SMALL MOLECULE INHIBITORS OF BACTERIAL EFFLUX PUMPS AND METHODS OF USING SAME 
023 20220175738
 
Tip60 Inhibitors and Methods of Use for Cardiovascular Disease 
024 20220175742
 
COLLAGEN P4H1 INHIBITOR AND ITS USE 
025 20220175750
 
SUSTAINED RELEASE FORMULATION FOR LOCAL DELIVERY OF CDK9 INHIBITORS 
026 20220175763
 
COMPOSITIONS AND METHODS FOR ENHANCING CANCER IMMUNE CHECKPOINT THERAPY 
027 20220175767
 
Uses of Bcl-2 Antagonists for Treating Cancer and Diagnostics Related Thereto 
028 20220175777
 
Inhibitors of Multidrug Resistance Transporter P-Glycoprotein 
029 20220175778
 
COMPOUNDS WITH ANTI-TUMOR ACTIVITY AGAINST CANCER CELLS BEARING HER2 EXON 21 INSERTIONS 
030 20220175791
 
Methods for Predicting Neisseria Spp. Susceptibility to Cefixime 
031 20220175804
 
aPKC INHIBITORS AND METHODS OF TREATING A NEURODEGENERATIVE DISEASE OR DISORDER 
032 20220175810
 
COMPOSITIONS AND METHODS FOR TREATING, AMELIORATING, AND/OR PREVENTING VIRAL INFECTIONS 
033 20220175816
 
AIM2 INHIBITORS AND USES THEREOF 
034 20220175833
 
TARGETED DELIVERY OF IMMUNE-MODULATING VHH AND VHH-FUSION PROTEIN 
035 20220175836
 
PRIMING WITH TARGETED ACTIVATED T CELLS CAN ENHANCE CHEMO RESPONSIVENESS OF CANCER CELLS 
036 20220175844
 
METHODS OF TREATING OPTIC NERVE DISEASES USING NEURAL PROGENITOR CELL GROWTH FACTORS 
037 20220175845
 
MULTICISTRONIC MIRNA DELIVERY FOR CARDIAC REPROGRAMMING 
038 20220175851
 
COMPOSITIONS, METHODS FOR REGULATING UTERINE, PLACENTAL GROWTH 
039 20220175856
 
UNRAVELING RECEPTOR-METABOLITE INTERACTIONS IN THE HUMAN MICROBIOME 
040 20220175870
 
Therapeutic Compositions Directed To Host Mirna For The Treatment Of Sars-Cov-2 (Covid-19) Infection 
041 20220175872
 
THERMOGENIC COMPOSITIONS AND METHODS 
042 20220175877
 
METHODS AND COMPOSITIONS COMPRISING A C-TERMINAL BAX PEPTIDE 
043 20220175886
 
NET STABILIZATION AS A THERAPY FOR SEPSIS 
044 20220175892
 
Pyocyanine Demethylases and related Phenazine Degrading Agents Compositions, Methods and Systems for Interfering with Viability of Bacteria 
045 20220175904
 
METHODS AND COMPOSITIONS RELATING TO SYNTHETIC BETA-1,6 GLUCOSAMINE OLIGOSACCHARIDES 
046 20220175935
 
RNA Aptamers and Uses Thereof 
047 20220175936
 
ANTIVIRAL PRODRUGS AND NANOFORMULATIONS THEREOF 
048 20220175941
 
METHODS AND COMPOSITIONS USING PEPTIDES AND PROTEINS WITH C-TERMINAL ELEMENTS 
049 20220175953
 
BIOMIMETIC ANISOTROPIC POLYMERIC PARTICLES WITH NATURALLY DERIVED CELL MEMBRANES FOR ENHANCED DRUG DELIVERY 
050 20220175956
 
HAIRPIN-LIKE OLIGONUCLEOTIDE-CONJUGATED SPHERICAL NUCLEIC ACID 
051 20220175957
 
DELIVERY OF MACROMOLECULES INTO THE CENTRAL NERVOUS SYSTEM VIA THE BLOODSTREAM 
052 20220175964
 
DYSTROPHIN R16/R17 SYNTROPHIN PDZ FUSION PROTEINS 
053 20220175969
 
ENHANCED HUMAN OPSIN PROMOTER FOR ROD SPECIFIC EXPRESSION 
054 20220175975
 
HER3 Peptides for Imaging and Radiotherapy 
055 20220175978
 
FUNCTIONALIZED SILICA NANORINGS, METHODS OF MAKING SAME, AND USES THEREOF 
056 20220175981
 
SUPPORTED X-RAY HORN FOR CONTROLLING E-BEAMS 
057 20220176017
 
BIOPOLYMER SCAFFOLD IMPLANTS AND METHODS FOR THEIR PRODUCTION 
058 20220176096
 
MICRONEEDLES TO DELIVER THERAPEUTIC AGENT ACROSS MEMBRANES 
059 20220176177
 
ADJUSTABLE NOZZLE AND METHOD OF OPERATION 
060 20220176321
 
System and Process for Hybrid Membrane Distillation-Pervaporation 
061 20220176346
 
AMINE FUNCTIONALIZED CHITIN FOR REMOVING SUBSTANCES FROM SOLUTIONS 
062 20220176377
 
SOLID-STATE, MULTI-WELL PLATE READER 
063 20220176422
 
GREENHOUSE GAS EMISSIONS CONTROL 
064 20220176495
 
SYSTEM AND METHOD FOR RADIUS OF CURVATURE MODIFICATION OF OPTICAL PLATES AND LENSES BY IRRADIATION WITH OPTICAL ENERGY 
065 20220176563
 
SYSTEMS AND METHODS FOR DISTRIBUTED TRAINING AND MANAGEMENT OF AI-POWERED ROBOTS USING TELEOPERATION VIA VIRTUAL SPACES 
066 20220176651
 
Method and Devices to Construct Artificial Inline Defects to Calibrate Inspection Hardware on Automated Fiber Placement Systems 
067 20220177109
 
DETECT AND AVOID SENSOR INTEGRATION 
068 20220177127
 
Enclosure For An Unmanned Aerial System 
069 20220177327
 
AEROSOL-BASED HIGH-TEMPERATURE SYNTHESIS OF MATERIALS WITH COMPOSITIONAL GRADIENT 
070 20220177331
 
IN SITU OIL CLEANUP AND RECOVERY USING SMART POLYMER INTEGRATED SURFACE VESSELS 
071 20220177379
 
PROCESSING METHOD FOR PIP DERIVED CMC ARTICLE 
072 20220177418
 
INHIBITORS OF THE N-TERMINAL DOMAIN OF THE ANDROGEN RECEPTOR 
073 20220177422
 
REMODILINS FOR AIRWAY REMODELING AND ORGAN FIBROSIS 
074 20220177425
 
SMALL MOLECULES FOR CANCER THERAPY THAT REDUCE THE EXPRESSION OF TRANSCRIPTION FACTORS KLF5 AND EGR-1 
075 20220177443
 
SMALL MOLECULE DEGRADERS OF HELIOS AND METHODS OF USE 
076 20220177452
 
2-Pyrimidone Analogs as Potent Antiviral Agents Against Alphaviruses 
077 20220177457
 
SMALL MOLECULES THAT BIND CYCLIN-DEPENDENT KINASE INHIBITOR 1B (P27KIP1) 
078 20220177464
 
HCK INHIBITORS FOR THE TREATMENT OF FIBROSIS AND CANCER 
079 20220177466
 
DEGRADERS OF KELCH-LIKE ECH-ASSOCIATED PROTEIN 1 (KEAP1) 
080 20220177472
 
IMIDAZOQUINOLINE COMPOUNDS AND PRODRUGS THEREOF 
081 20220177488
 
SUMO INHIBITOR COMPOUNDS AND USES THEREOF 
082 20220177489
 
Next Generation Synthetic Transcription Factors 
083 20220177523
 
CELL PENETRATING PEPTIDES AND METHODS OF MAKING AND USING THEREOF 
084 20220177527
 
METHODS OF DETECTING AND TREATING HEREDITARY SPASTIC PARAPLEGIA 
085 20220177531
 
Selective and Noncovalent Inhibitors of Oncogenic RAS Mutants 
086 20220177534
 
CCL21 AND CHECKPOINT INHIBITORS FOR THE TREATMENT OF CANCER 
087 20220177548
 
Methods and Compositions for Treating Melanoma 
088 20220177556
 
HUMANIZED ANTI-C5 ANTIBODIES AND USES THEREOF 
089 20220177559
 
COMPOSITIONS AND METHODS TO TREAT VIRAL INFECTION AND CO-MORBIDITIES 
090 20220177561
 
Models and Methods Useful for the Treatment of Serrated Colorectal Cancer 
091 20220177598
 
TARGETED DELIVERY OF IFN GAMMA USING ANTIBODY FUSION PROTEINS 
092 20220177605
 
CHEMICALLY INDUCED PROTEIN DIMERIZATION SYSTEMS 
093 20220177664
 
Graphene Composite Matrices and Uses Thereof 
094 20220177703
 
\'SMART\' HYDROGEL FOR THE RADIOSENSITIZATION AND SUSTAINED DELIVERY OF THERAPEUTICS TRIGGERED BY IRRADIATION 
095 20220177704
 
MIXTURES OF SYNTHETIC COPOLYPEPTIDE HYDROGELS 
096 20220177754
 
CURABLE COATING COMPOSITIONS 
097 20220177765
 
AEROGEL COMPOSITES INCLUDING PHASE CHANGE MATERIALS 
098 20220177838
 
CYTOPHERESIS CARTRIDGES AND USE THEREOF 
099 20220177843
 
COMPOSITIONS AND METHODS FOR INCREASING MEGAKARYOCYTE PRODUCTION 
100 20220177845
 
PRODUCTION OF RED BLOOD CELLS AND PLATELETS FROM STEM CELLS 
101 20220177847
 
PLATFORM FOR GENERATING SAFE CELL THERAPEUTICS 
102 20220177853
 
METHODS FOR CONTROLLED INDUCTION OF BIOENGINEERED NEUROEPITHELIAL TISSUES AND 3-D NEUROEPITHELIAL TUBES 
103 20220177856
 
METHODS AND COMPOSITIONS FOR PRODUCING ACTIVE VITAMIN K-DEPENDENT PROTEINS 
104 20220177862
 
Precise Gene Activation Via Novel Designed Proteins Mediating Epigenetic Remodeling 
105 20220177863
 
TYPE VII CRISPR PROTEINS AND SYSTEMS 
106 20220177866
 
Compositions and Methods for Modulating Growth of a Genetically Modified Gut Bacterial Cell 
107 20220177867
 
NOVEL BOTULINUM NEUROTOXIN AND ITS DERIVATIVES 
108 20220177869
 
METHOD OF GENERATING TARGETED DNA LIBRARIES 
109 20220177878
 
CRISPR/CAS9 GENE EDITING OF ATXN2 FOR THE TREATMENT OF SPINOCEREBELLAR ATAXIA TYPE 2 
110 20220177879
 
CRISPR/CAS-BASED BASE EDITING COMPOSITION FOR RESTORING DYSTROPHIN FUNCTION 
111 20220177889
 
MICRORNA-198 AS A TUMOR SUPPRESSOR IN OVARIAN CANCER 
112 20220177890
 
HYBRID NUCLEIC ACID SWITCHES 
113 20220177905
 
Compositions and Methods for Allelic Gene Drive Systems and Lethal Mosaicism 
114 20220177911
 
SYNTHETIC CIRCUIT FOR CELLULAR MULTISTABILITY 
115 20220177913
 
RNA-Guided Human Genome Engineering 
116 20220177941
 
RIBOSOME VARIANTS FOR SEQUENCE DEFINED POLYMER SYNTHESIS 
117 20220177947
 
Compounds to Identify Beta-Lactamases, and Methods of Use Thereof 
118 20220177963
 
PAIRED MACROMOLECULE ABUNDANCE AND T-CELL RECEPTOR SEQUENCING WITH HIGH SPATIAL RESOLUTION 
119 20220178036
 
SEPARATION AND CONVERSION OF CARBON DIOXIDE TO SYNGAS USING A POROUS CERAMIC DUAL MEMBRANE IN A THERMO-ELECTROCHEMICAL REACTOR 
120 20220178042
 
OIL-IMPREGNATED NANOPOROUS OXIDE COATING FOR INHIBITING ALUMINUM CORROSION 
121 20220178813
 
Parallel Flow Cytometer Using Radiofrequency Multiplexing 
122 20220178831
 
Graphene Hybrids for Biological and Chemical Sensing 
123 20220178834
 
METHOD AND APPARATUS FOR CONTINUOUS GAS MONITORING USING MICRO-COLORIMETRIC SENSING AND OPTICAL TRACKING OF COLOR SPATIAL DISTRIBUTION 
124 20220178852
 
MULTIPLEXED COMPUTED TOMOGRAPHY X-RAY IMAGING 
125 20220178859
 
METAL NANOPARTICLE-DECORATED NANOTUBES FOR GAS SENSING 
126 20220178910
 
IFNbeta as a Pharmacodynamic Marker in VSV-IFNbeta-NIS Oncolytic Therapy 
127 20220178911
 
Synthetic Lethality Screening Platform for Cells Undergoing ALT 
128 20220178912
 
FIBROSIS MODEL AND METHODS OF USE THEREOF 
129 20220178924
 
SYSTEMS AND METHODS FOR IDENTIFYING SUBTYPE, PROGNOSIS, AND MONITORING OF BREAST CANCER 
130 20220178925
 
MULTIGENE ASSAY TO ASSESS RISK OF RECURRENCE OF CANCER 
131 20220178950
 
DISCOVERY AND VALIDATION OF AN EARLY POST-TRANSPLANT BIOMARKER PREDICTIVE OF CHRONIC KIDNEY DISEASE IN LIVER TRANSPLANT RECIPIENTS 
132 20220178953
 
METHODS FOR ASSESSING CARDIOVASCULAR DISEASE OR INFLAMMATORY DISEASE RISK USING NON-EXCHANGEABLE LIPID PROBE 
133 20220178954
 
STRATIFICATION BY SEX AND APOE GENOTYPE IDENTIFIES METABOLIC HETEROGENEITY IN ALZHEIMER\'S DISEASE 
134 20220178983
 
ELECTRONIC DEVICE CHARACTERIZATION SYSTEMS AND METHODS 
135 20220179022
 
METHOD FOR DESIGNING ELECTROMAGNETIC COILS WITH EXPLICIT PERIPHERAL NERVE STIMULATION CONSTRAINT BASED ON AN ORACLE PENALTY 
136 20220179024
 
MULTI-SHOT ECHO PLANAR IMAGING USING REORDERED SEGMENTS AND RECURSIVE RADIO FREQUENCY PULSE DESIGN GIVING MATCHED SLICE PROFILES ACROSS SEGMENTS 
137 20220179030
 
FAST DIFFUSION TENSOR MRI USING DEEP LEARNING 
138 20220179244
 
TIME-VARYING METASURFACE STRUCTURE 
139 20220179281
 
PROGRAMMING EMERGENT SYMMETRIES WITH SADDLE-SPLAY ELASTICITY 
140 20220179283
 
ULTRA-LOW-NOISE, ON-CHIP QUANTUM DEVICES 
141 20220179284
 
Electrically Tunable Quantum Information Processing Device Based on a Doped Semiconductor Structure Embedded with a Defect 
142 20220179285
 
PHOTONIC AC-DC EQUIVALENCE CONVERTER AND PERFORMING AC-DC EQUIVALENCE CONVERSION 
143 20220179378
 
Blockchain-Based Transactive Energy Systems 
144 20220179417
 
Systems and Methods for Ground Plane Estimation 
145 20220179465
 
SENSOR-BASED NON-UNIFORM COOLING 
146 20220179891
 
SYSTEMS AND METHODS FOR PROVIDING SIMILARITY-BASED RETRIEVAL OF INFORMATION STORED IN DNA 
147 20220180028
 
DOWNHOLE ELECTRODE PLACEMENT OPTIMIZATION 
148 20220180083
 
MODIFYING MESSAGES STORED IN MIXTURES OF MOLECULES USING THIN-LAYER CHROMATOGRAPHY 
149 20220180084
 
SYSTEM AND METHOD FOR EXTRACTING A COMPUTER READABLE CODE FROM A CAPTURED IMAGE OF A DISTRIBUTION ITEM 
150 20220180465
 
SYSTEMS AND METHODS FOR TRACKING DISASTER FOOTPRINTS WITH SOCIAL STREAMING DATA 
151 20220180482
 
K-SPACE BASED METHOD FOR REDUCING NOISE AND DOSE OF RADIATION OR CONTRAST FOR PERFUSION IMAGING 
152 20220180745
 
SYSTEMS AND METHODS FOR SYSTEM OPTIMAL TRAFFIC ROUTING 
153 20220181006
 
UNIVERSAL IMAGE REPRESENTATION BASED ON A MULTIMODAL GRAPH 
154 20220181507
 
Physical Forms of MXene Materials Exhibiting Novel Electrical And Optical Characteristics 
155 20220181566
 
BALLISTIC EXCITON TRANSISTOR 
156 20220181573
 
OPTOELECTRONIC DEVICE INCLUDING ULTRATHIN DOPANT LAYERS 
157 20220181607
 
CARBON FOAMS, DOPED CARBON COMPOSITES, PROCESSES FOR FABRICATING CARBON FOAMS AND DOPED CARBON COMPOSITES, AND USES THEREOF 
158 20220181618
 
LOW-COBALT AND COBALT-FREE, HIGH-ENERGY CATHODE MATERIALS FOR LITHIUM BATTERIES 
159 20220181771
 
Antenna Assemblies and Antenna Systems 
160 20220181843
 
CTE-TUNED PYROLYTIC GRAPHITE (PG) SUBSTRATE TO MINIMIZE JOINING STRESS BETWEEN LASER DIODE AND THE SUBSTRATE 
161 20220181877
 
VOLTAGE WAVEFORM TRANSIENT IDENTIFICATION AND AUTONOMOUS LOAD COORDINATION 
162 20220182070
 
APPARATUSES AND METHODS INVOLVING DC VOLTAGE CONVERSION USING PHOTONIC TRANSFORMERS 
163 20220182092
 
ULTRA-LOW-POWER MILLIMETER-WAVE TO BASEBAND RECEIVER MODULE FOR SCALABLE MASSIVE MIMO 
164 20220182309
 
OPTIMIZED ADAPTIVE ROUTING TO REDUCE NUMBER OF HOPS 
165 20220182351
 
SYSTEMS AND METHODS FOR UNSUPERVISED CYBERBULLYING DETECTION VIA TIME-INFORMED GAUSSIAN MIXTURE MODEL 
166 20220182400
 
CONTEXT-AWARE SECURITY FRAMEWORK FOR A SMART ENVIRONMENT 
167 20220182402
 
IN-VEHICLE NETWORK INTRUSION DETECTION USING UNSUPERVISED LEARNING 

Up to Start Of Table

Patent Applications Count By Department

The count of taxpayer-funded patents granted by the United States Patent and Trademark Office (USPTO) this week that contain a Government Interest Statement in the body of the patent documents or where the government is an assignee. Agency numbers are aggregated by the agency named in the Government Interests Statement and the contract number cited in the patent.

Department This Week This Year
Department of Health and Human Services (HHS) 104 1820
Department of Defense (DOD) 31 836
National Science Foundation (NSF) 25 627
Department of Energy (DOE) 16 628
Department of Veterans Affairs (DVA) 4 43
National Aeronautics and Space Administration (NASA) 3 104
Small Business Administration (SBA) 3 61
Department of Agriculture (USDA) 2 76
Department of Commerce (DOC) 2 31
Department of Homeland Security (DHS) 1 41
Department of Transportation (USDOT) 1 14
Environmental Protection Agency (EPA) 1 6
National Security Agency (NSA) 1 14
Non-Profit Organization (NPO) 1 20
United States Postal Service (USPS) 1 18

Patent Applications by Funding Agency

FedInvent Patents reflects patents with Government Interests Statements in the body of the patent as required by the Bayh-Dole Act indicating the holder of a federal contract, grant, or cooperative agreement has elected to retain the title of inventions conceived and reduced to practice during that contract; and patents where an agency of the US Federal government has elected to retain the title to the patent.

About The Icons On the List Below

  • The icon takes you to the full text version of the patent application at USPTO;
  • The icon takes you to the PDF version of the patent application at USPTO; and
  • The icon takes you to the details about the patent on the FedInvent Details page.
  • When you use the icon the patent you are interested appears at the top of the list on the details page.

Click the Panel to See The Patent Application for Each Agency

Take Me To The Details
Patent Title
001 20220174962
 
ENZYME-LOADED POLLEN-MIMICKING MICROPARTICLES FOR ORGANOPHOSPHATE DETOXIFICATION OF INSECT POLLINATORS 
002 20220174963
 
COMPOSITIONS AND METHODS RELATING TO INSECTICIDES 
003 20220175006
 
FASTING MIMICKING KETOGENIC DIET (FMD) TO PROMOTE SKELETAL MUSCLE REGENERATION AND STRENGTH 
004 20220175007
 
FASTING MIMICKING KETOGENIC DIET TO IMPROVE IMMUNE FUNCTION AND VACCINE RESPONSE AND MINIMIZE RISK IN ADULTS AND ELDERLY 
005 20220175253
 
REVERSIBLY SWITCHABLE PHOTOACOUSTIC IMAGING SYSTEMS AND METHODS 
006 20220175285
 
TRANSLATIONAL METHOD TO DETERMINE BIOLOGICAL BASIS FOR DYSLEXIA 
007 20220175341
 
Device, System, and Method For Hemispheric Breast Imaging 
008 20220175413
 
APPARATUSES, SYSTEMS AND METHODS FOR PERFORATING AND ASPIRATING INNER EAR 
009 20220175510
 
BIOMEDICAL PATCHES WITH ALIGNED FIBERS 
010 20220175681
 
SELF-RIGHTING ARTICLES 
011 20220175687
 
NANOPARTICLES FOR DRUG DELIVERY TO BRAIN 
012 20220175700
 
VISUAL CYCLE MODULATORS 
013 20220175704
 
SENSITIZATION OF CANCER CELLS TO DIFFERENTIATION THERAPY WITH MITOCHONDRIAL UNCOUPLER NICLOSAMIDE ETHANOLAMINE 
014 20220175705
 
DISULFIDE-MASKED PRO-CHELATOR COMPOSITIONS AND METHODS OF USE 
015 20220175722
 
DEGRADERS OF FIBROBLAST GROWTH FACTOR RECEPTOR 2 (FGFR2) 
016 20220175730
 
Effects of Age-Dependent Changes in Cell Size on Endothelial Cell Growth 
017 20220175736
 
SMALL MOLECULE INHIBITORS OF BACTERIAL EFFLUX PUMPS AND METHODS OF USING SAME 
018 20220175738
 
Tip60 Inhibitors and Methods of Use for Cardiovascular Disease 
019 20220175742
 
COLLAGEN P4H1 INHIBITOR AND ITS USE 
020 20220175750
 
SUSTAINED RELEASE FORMULATION FOR LOCAL DELIVERY OF CDK9 INHIBITORS 
021 20220175763
 
COMPOSITIONS AND METHODS FOR ENHANCING CANCER IMMUNE CHECKPOINT THERAPY 
022 20220175767
 
Uses of Bcl-2 Antagonists for Treating Cancer and Diagnostics Related Thereto 
023 20220175777
 
Inhibitors of Multidrug Resistance Transporter P-Glycoprotein 
024 20220175778
 
COMPOUNDS WITH ANTI-TUMOR ACTIVITY AGAINST CANCER CELLS BEARING HER2 EXON 21 INSERTIONS 
025 20220175791
 
Methods for Predicting Neisseria Spp. Susceptibility to Cefixime 
026 20220175804
 
aPKC INHIBITORS AND METHODS OF TREATING A NEURODEGENERATIVE DISEASE OR DISORDER 
027 20220175810
 
COMPOSITIONS AND METHODS FOR TREATING, AMELIORATING, AND/OR PREVENTING VIRAL INFECTIONS 
028 20220175816
 
AIM2 INHIBITORS AND USES THEREOF 
029 20220175836
 
PRIMING WITH TARGETED ACTIVATED T CELLS CAN ENHANCE CHEMO RESPONSIVENESS OF CANCER CELLS 
030 20220175844
 
METHODS OF TREATING OPTIC NERVE DISEASES USING NEURAL PROGENITOR CELL GROWTH FACTORS 
031 20220175845
 
MULTICISTRONIC MIRNA DELIVERY FOR CARDIAC REPROGRAMMING 
032 20220175851
 
COMPOSITIONS, METHODS FOR REGULATING UTERINE, PLACENTAL GROWTH 
033 20220175856
 
UNRAVELING RECEPTOR-METABOLITE INTERACTIONS IN THE HUMAN MICROBIOME 
034 20220175872
 
THERMOGENIC COMPOSITIONS AND METHODS 
035 20220175877
 
METHODS AND COMPOSITIONS COMPRISING A C-TERMINAL BAX PEPTIDE 
036 20220175886
 
NET STABILIZATION AS A THERAPY FOR SEPSIS 
037 20220175892
 
Pyocyanine Demethylases and related Phenazine Degrading Agents Compositions, Methods and Systems for Interfering with Viability of Bacteria 
038 20220175904
 
METHODS AND COMPOSITIONS RELATING TO SYNTHETIC BETA-1,6 GLUCOSAMINE OLIGOSACCHARIDES 
039 20220175935
 
RNA Aptamers and Uses Thereof 
040 20220175936
 
ANTIVIRAL PRODRUGS AND NANOFORMULATIONS THEREOF 
041 20220175941
 
METHODS AND COMPOSITIONS USING PEPTIDES AND PROTEINS WITH C-TERMINAL ELEMENTS 
042 20220175953
 
BIOMIMETIC ANISOTROPIC POLYMERIC PARTICLES WITH NATURALLY DERIVED CELL MEMBRANES FOR ENHANCED DRUG DELIVERY 
043 20220175956
 
HAIRPIN-LIKE OLIGONUCLEOTIDE-CONJUGATED SPHERICAL NUCLEIC ACID 
044 20220175957
 
DELIVERY OF MACROMOLECULES INTO THE CENTRAL NERVOUS SYSTEM VIA THE BLOODSTREAM 
045 20220175964
 
DYSTROPHIN R16/R17 SYNTROPHIN PDZ FUSION PROTEINS 
046 20220175969
 
ENHANCED HUMAN OPSIN PROMOTER FOR ROD SPECIFIC EXPRESSION 
047 20220175978
 
FUNCTIONALIZED SILICA NANORINGS, METHODS OF MAKING SAME, AND USES THEREOF 
048 20220176096
 
MICRONEEDLES TO DELIVER THERAPEUTIC AGENT ACROSS MEMBRANES 
049 20220177418
 
INHIBITORS OF THE N-TERMINAL DOMAIN OF THE ANDROGEN RECEPTOR 
050 20220177422
 
REMODILINS FOR AIRWAY REMODELING AND ORGAN FIBROSIS 
051 20220177425
 
SMALL MOLECULES FOR CANCER THERAPY THAT REDUCE THE EXPRESSION OF TRANSCRIPTION FACTORS KLF5 AND EGR-1 
052 20220177443
 
SMALL MOLECULE DEGRADERS OF HELIOS AND METHODS OF USE 
053 20220177452
 
2-Pyrimidone Analogs as Potent Antiviral Agents Against Alphaviruses 
054 20220177457
 
SMALL MOLECULES THAT BIND CYCLIN-DEPENDENT KINASE INHIBITOR 1B (P27KIP1) 
055 20220177464
 
HCK INHIBITORS FOR THE TREATMENT OF FIBROSIS AND CANCER 
056 20220177466
 
DEGRADERS OF KELCH-LIKE ECH-ASSOCIATED PROTEIN 1 (KEAP1) 
057 20220177472
 
IMIDAZOQUINOLINE COMPOUNDS AND PRODRUGS THEREOF 
058 20220177488
 
SUMO INHIBITOR COMPOUNDS AND USES THEREOF 
059 20220177489
 
Next Generation Synthetic Transcription Factors 
060 20220177523
 
CELL PENETRATING PEPTIDES AND METHODS OF MAKING AND USING THEREOF 
061 20220177527
 
METHODS OF DETECTING AND TREATING HEREDITARY SPASTIC PARAPLEGIA 
062 20220177531
 
Selective and Noncovalent Inhibitors of Oncogenic RAS Mutants 
063 20220177534
 
CCL21 AND CHECKPOINT INHIBITORS FOR THE TREATMENT OF CANCER 
064 20220177548
 
Methods and Compositions for Treating Melanoma 
065 20220177556
 
HUMANIZED ANTI-C5 ANTIBODIES AND USES THEREOF 
066 20220177559
 
COMPOSITIONS AND METHODS TO TREAT VIRAL INFECTION AND CO-MORBIDITIES 
067 20220177561
 
Models and Methods Useful for the Treatment of Serrated Colorectal Cancer 
068 20220177598
 
TARGETED DELIVERY OF IFN GAMMA USING ANTIBODY FUSION PROTEINS 
069 20220177605
 
CHEMICALLY INDUCED PROTEIN DIMERIZATION SYSTEMS 
070 20220177664
 
Graphene Composite Matrices and Uses Thereof 
071 20220177703
 
\'SMART\' HYDROGEL FOR THE RADIOSENSITIZATION AND SUSTAINED DELIVERY OF THERAPEUTICS TRIGGERED BY IRRADIATION 
072 20220177838
 
CYTOPHERESIS CARTRIDGES AND USE THEREOF 
073 20220177843
 
COMPOSITIONS AND METHODS FOR INCREASING MEGAKARYOCYTE PRODUCTION 
074 20220177845
 
PRODUCTION OF RED BLOOD CELLS AND PLATELETS FROM STEM CELLS 
075 20220177847
 
PLATFORM FOR GENERATING SAFE CELL THERAPEUTICS 
076 20220177853
 
METHODS FOR CONTROLLED INDUCTION OF BIOENGINEERED NEUROEPITHELIAL TISSUES AND 3-D NEUROEPITHELIAL TUBES 
077 20220177856
 
METHODS AND COMPOSITIONS FOR PRODUCING ACTIVE VITAMIN K-DEPENDENT PROTEINS 
078 20220177862
 
Precise Gene Activation Via Novel Designed Proteins Mediating Epigenetic Remodeling 
079 20220177863
 
TYPE VII CRISPR PROTEINS AND SYSTEMS 
080 20220177866
 
Compositions and Methods for Modulating Growth of a Genetically Modified Gut Bacterial Cell 
081 20220177867
 
NOVEL BOTULINUM NEUROTOXIN AND ITS DERIVATIVES 
082 20220177869
 
METHOD OF GENERATING TARGETED DNA LIBRARIES 
083 20220177878
 
CRISPR/CAS9 GENE EDITING OF ATXN2 FOR THE TREATMENT OF SPINOCEREBELLAR ATAXIA TYPE 2 
084 20220177879
 
CRISPR/CAS-BASED BASE EDITING COMPOSITION FOR RESTORING DYSTROPHIN FUNCTION 
085 20220177889
 
MICRORNA-198 AS A TUMOR SUPPRESSOR IN OVARIAN CANCER 
086 20220177890
 
HYBRID NUCLEIC ACID SWITCHES 
087 20220177905
 
Compositions and Methods for Allelic Gene Drive Systems and Lethal Mosaicism 
088 20220177913
 
RNA-Guided Human Genome Engineering 
089 20220177947
 
Compounds to Identify Beta-Lactamases, and Methods of Use Thereof 
090 20220177963
 
PAIRED MACROMOLECULE ABUNDANCE AND T-CELL RECEPTOR SEQUENCING WITH HIGH SPATIAL RESOLUTION 
091 20220178834
 
METHOD AND APPARATUS FOR CONTINUOUS GAS MONITORING USING MICRO-COLORIMETRIC SENSING AND OPTICAL TRACKING OF COLOR SPATIAL DISTRIBUTION 
092 20220178910
 
IFNbeta as a Pharmacodynamic Marker in VSV-IFNbeta-NIS Oncolytic Therapy 
093 20220178911
 
Synthetic Lethality Screening Platform for Cells Undergoing ALT 
094 20220178912
 
FIBROSIS MODEL AND METHODS OF USE THEREOF 
095 20220178924
 
SYSTEMS AND METHODS FOR IDENTIFYING SUBTYPE, PROGNOSIS, AND MONITORING OF BREAST CANCER 
096 20220178925
 
MULTIGENE ASSAY TO ASSESS RISK OF RECURRENCE OF CANCER 
097 20220178950
 
DISCOVERY AND VALIDATION OF AN EARLY POST-TRANSPLANT BIOMARKER PREDICTIVE OF CHRONIC KIDNEY DISEASE IN LIVER TRANSPLANT RECIPIENTS 
098 20220178953
 
METHODS FOR ASSESSING CARDIOVASCULAR DISEASE OR INFLAMMATORY DISEASE RISK USING NON-EXCHANGEABLE LIPID PROBE 
099 20220178954
 
STRATIFICATION BY SEX AND APOE GENOTYPE IDENTIFIES METABOLIC HETEROGENEITY IN ALZHEIMER\'S DISEASE 
100 20220178983
 
ELECTRONIC DEVICE CHARACTERIZATION SYSTEMS AND METHODS 
101 20220179022
 
METHOD FOR DESIGNING ELECTROMAGNETIC COILS WITH EXPLICIT PERIPHERAL NERVE STIMULATION CONSTRAINT BASED ON AN ORACLE PENALTY 
102 20220179024
 
MULTI-SHOT ECHO PLANAR IMAGING USING REORDERED SEGMENTS AND RECURSIVE RADIO FREQUENCY PULSE DESIGN GIVING MATCHED SLICE PROFILES ACROSS SEGMENTS 
103 20220179030
 
FAST DIFFUSION TENSOR MRI USING DEEP LEARNING 
104 20220180482
 
K-SPACE BASED METHOD FOR REDUCING NOISE AND DOSE OF RADIATION OR CONTRAST FOR PERFUSION IMAGING 

Up to Start Of Table

Take Me To The Details

Department of Defense (DOD) Agencies

Patent Title
001 20220175254
 
NEAR-FIELD COHERENT SENSING METHODS AND SYSTEMS 
002 20220175306
 
NEUROMODULATION TO TARGET GLUCOSE TRANSPORTER AND/OR INCRETIN PATHWAYS 
003 20220175935
 
RNA Aptamers and Uses Thereof 
004 20220175941
 
METHODS AND COMPOSITIONS USING PEPTIDES AND PROTEINS WITH C-TERMINAL ELEMENTS 
005 20220175975
 
HER3 Peptides for Imaging and Radiotherapy 
006 20220176017
 
BIOPOLYMER SCAFFOLD IMPLANTS AND METHODS FOR THEIR PRODUCTION 
007 20220177911
 
SYNTHETIC CIRCUIT FOR CELLULAR MULTISTABILITY 
008 20220177941
 
RIBOSOME VARIANTS FOR SEQUENCE DEFINED POLYMER SYNTHESIS 
009 20220178912
 
FIBROSIS MODEL AND METHODS OF USE THEREOF 
010 20220179465
 
SENSOR-BASED NON-UNIFORM COOLING 
011 20220182070
 
APPARATUSES AND METHODS INVOLVING DC VOLTAGE CONVERSION USING PHOTONIC TRANSFORMERS 

Department of the ARMY (DOA)

Patent Title
001 20220175254
 
NEAR-FIELD COHERENT SENSING METHODS AND SYSTEMS 
002 20220175750
 
SUSTAINED RELEASE FORMULATION FOR LOCAL DELIVERY OF CDK9 INHIBITORS 
003 20220175941
 
METHODS AND COMPOSITIONS USING PEPTIDES AND PROTEINS WITH C-TERMINAL ELEMENTS 
004 20220175964
 
DYSTROPHIN R16/R17 SYNTROPHIN PDZ FUSION PROTEINS 
005 20220175975
 
HER3 Peptides for Imaging and Radiotherapy 
006 20220176346
 
AMINE FUNCTIONALIZED CHITIN FOR REMOVING SUBSTANCES FROM SOLUTIONS 
007 20220177127
 
Enclosure For An Unmanned Aerial System 
008 20220177754
 
CURABLE COATING COMPOSITIONS 
009 20220177765
 
AEROGEL COMPOSITES INCLUDING PHASE CHANGE MATERIALS 
010 20220177838
 
CYTOPHERESIS CARTRIDGES AND USE THEREOF 
011 20220177941
 
RIBOSOME VARIANTS FOR SEQUENCE DEFINED POLYMER SYNTHESIS 
012 20220178813
 
Parallel Flow Cytometer Using Radiofrequency Multiplexing 
013 20220178912
 
FIBROSIS MODEL AND METHODS OF USE THEREOF 
014 20220179244
 
TIME-VARYING METASURFACE STRUCTURE 
015 20220179891
 
SYSTEMS AND METHODS FOR PROVIDING SIMILARITY-BASED RETRIEVAL OF INFORMATION STORED IN DNA 
016 20220180083
 
MODIFYING MESSAGES STORED IN MIXTURES OF MOLECULES USING THIN-LAYER CHROMATOGRAPHY 
017 20220182070
 
APPARATUSES AND METHODS INVOLVING DC VOLTAGE CONVERSION USING PHOTONIC TRANSFORMERS 
018 20220182402
 
IN-VEHICLE NETWORK INTRUSION DETECTION USING UNSUPERVISED LEARNING 

Department of the Navy (DON) | United States Marine Corps (USMC)

Patent Title
001 20220177331
 
IN SITU OIL CLEANUP AND RECOVERY USING SMART POLYMER INTEGRATED SURFACE VESSELS 
002 20220177379
 
PROCESSING METHOD FOR PIP DERIVED CMC ARTICLE 
003 20220177457
 
SMALL MOLECULES THAT BIND CYCLIN-DEPENDENT KINASE INHIBITOR 1B (P27KIP1) 
004 20220178042
 
OIL-IMPREGNATED NANOPOROUS OXIDE COATING FOR INHIBITING ALUMINUM CORROSION 
005 20220179284
 
Electrically Tunable Quantum Information Processing Device Based on a Doped Semiconductor Structure Embedded with a Defect 
006 20220181877
 
VOLTAGE WAVEFORM TRANSIENT IDENTIFICATION AND AUTONOMOUS LOAD COORDINATION 
007 20220182070
 
APPARATUSES AND METHODS INVOLVING DC VOLTAGE CONVERSION USING PHOTONIC TRANSFORMERS 

Department of the Air Force (DAF)| United States Space Force (USSF)

Patent Title
001 20220177331
 
IN SITU OIL CLEANUP AND RECOVERY USING SMART POLYMER INTEGRATED SURFACE VESSELS 
002 20220178831
 
Graphene Hybrids for Biological and Chemical Sensing 
003 20220179244
 
TIME-VARYING METASURFACE STRUCTURE 
004 20220179284
 
Electrically Tunable Quantum Information Processing Device Based on a Doped Semiconductor Structure Embedded with a Defect 
005 20220179465
 
SENSOR-BASED NON-UNIFORM COOLING 

Up to Start Of Table

Take Me To The Details
Patent Title
001 20220174962
 
ENZYME-LOADED POLLEN-MIMICKING MICROPARTICLES FOR ORGANOPHOSPHATE DETOXIFICATION OF INSECT POLLINATORS 
002 20220175510
 
BIOMEDICAL PATCHES WITH ALIGNED FIBERS 
003 20220175661
 
SYNERGIST THERAPY FOR ENHANCED DRUG DELIVERY: MAGNETIC FIELD FACILITATED NANOPARTICLE MICROPORATION 
004 20220175833
 
TARGETED DELIVERY OF IMMUNE-MODULATING VHH AND VHH-FUSION PROTEIN 
005 20220175978
 
FUNCTIONALIZED SILICA NANORINGS, METHODS OF MAKING SAME, AND USES THEREOF 
006 20220176177
 
ADJUSTABLE NOZZLE AND METHOD OF OPERATION 
007 20220176321
 
System and Process for Hybrid Membrane Distillation-Pervaporation 
008 20220176377
 
SOLID-STATE, MULTI-WELL PLATE READER 
009 20220176422
 
GREENHOUSE GAS EMISSIONS CONTROL 
010 20220176563
 
SYSTEMS AND METHODS FOR DISTRIBUTED TRAINING AND MANAGEMENT OF AI-POWERED ROBOTS USING TELEOPERATION VIA VIRTUAL SPACES 
011 20220177327
 
AEROSOL-BASED HIGH-TEMPERATURE SYNTHESIS OF MATERIALS WITH COMPOSITIONAL GRADIENT 
012 20220177331
 
IN SITU OIL CLEANUP AND RECOVERY USING SMART POLYMER INTEGRATED SURFACE VESSELS 
013 20220177704
 
MIXTURES OF SYNTHETIC COPOLYPEPTIDE HYDROGELS 
014 20220177853
 
METHODS FOR CONTROLLED INDUCTION OF BIOENGINEERED NEUROEPITHELIAL TISSUES AND 3-D NEUROEPITHELIAL TUBES 
015 20220177941
 
RIBOSOME VARIANTS FOR SEQUENCE DEFINED POLYMER SYNTHESIS 
016 20220178831
 
Graphene Hybrids for Biological and Chemical Sensing 
017 20220179244
 
TIME-VARYING METASURFACE STRUCTURE 
018 20220179281
 
PROGRAMMING EMERGENT SYMMETRIES WITH SADDLE-SPLAY ELASTICITY 
019 20220179284
 
Electrically Tunable Quantum Information Processing Device Based on a Doped Semiconductor Structure Embedded with a Defect 
020 20220180465
 
SYSTEMS AND METHODS FOR TRACKING DISASTER FOOTPRINTS WITH SOCIAL STREAMING DATA 
021 20220181507
 
Physical Forms of MXene Materials Exhibiting Novel Electrical And Optical Characteristics 
022 20220181607
 
CARBON FOAMS, DOPED CARBON COMPOSITES, PROCESSES FOR FABRICATING CARBON FOAMS AND DOPED CARBON COMPOSITES, AND USES THEREOF 
023 20220182092
 
ULTRA-LOW-POWER MILLIMETER-WAVE TO BASEBAND RECEIVER MODULE FOR SCALABLE MASSIVE MIMO 
024 20220182351
 
SYSTEMS AND METHODS FOR UNSUPERVISED CYBERBULLYING DETECTION VIA TIME-INFORMED GAUSSIAN MIXTURE MODEL 
025 20220182400
 
CONTEXT-AWARE SECURITY FRAMEWORK FOR A SMART ENVIRONMENT 

Up to Start Of Table

Emerging Technology

Emerging Climate Change Technologies

Patents containing 'Y" CPC symbols indicate emerging technologies important to US scientific leadership.

Patent documents that contain a Y02 or Y04 CPC symbol are already classified elsewhere. USPTO add the Y symbols to the classification data is to monitor new technological development covering clean technology and inventions impacting climate change, important American science and technology interests.

Y02 — Green House Gas Mitigation — Y02 covers selected technologies, which control, reduce or prevent anthropogenic emissions of greenhouse gases (GHG), in the framework of the Kyoto Protocol and the Paris Agreement, and technologies that allow adapting to the adverse effects of climate change. Y02A covers technologies for adaptation to climate change, — technologies that allow adapting to the adverse effects of climate change in human, industrial (including agriculture and livestock), and economic activities. Y02P covers climate change mitigation technologies in any kind of industrial processing or production activity, including the agroalimentary industry (relating to agriculture and food), agriculture, fishing, ranching, and the like.

Y04 — Enabling Technologies — Y04 is focused on the information and communications inventions that facilitate climate change technology. Y04S covers systems integrating technologies related to power network operation, communication or information technologies for improving electrical power generation, transmission, distribution, management, or usage. Examples of the art covered here are technologies related to smart grids, home appliances, and systems supporting the interoperability of electric or hybrid vehicles.

About The Icons On the List Below

  • The icon takes you to the full text version of the patent application at USPTO;
  • The icon takes you to the PDF version of the patent application at USPTO; and
  • The icon takes you to the details about the patent on the FedInvent Details page.
  • When you use the icon the patent application you are interested appears at the top of the list on the details page.
Class
Y02A Technologies for Adaptation to Climate Change
20220175285  TRANSLATIONAL METHOD TO DETERMINE BIOLOGICAL BASIS FOR DYSLEXIA      

Count of patent applications funded by The Department of Health and Human Services (HHS).

Department | Agency This Week This Year
Department of Health and Human Services (HHS) 104 1820
National Institutes of Health (NIH) 103 1754
National Cancer Institute (NCI) 33 452
National Institute of Allergy and Infectious Diseases (NIAID) 15 284
National Heart, Lung, and Blood Institute (NHLBI) 15 213
National Institute of Neurological Disorders and Stroke (NINDS) 10 149
National Institute of General Medical Sciences (NIGMS) 10 275
National Institute of Biomedical Imaging and Bioengineering (NIBIB) 9 130
NIH Office of the Director (NIHOD) 7 41
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 6 130
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 5 51
National Institute on Aging (NIA) 5 71
National Institute of Mental Health (NIMH) 3 63
National Institute on Deafness and Other Communication Disorders (NIDCD) 3 21
National Institute on Drug Abuse (NIDA) 3 25
National Eye Institute (NEI) 3 67
National Center for Research Resources (NCRR) 3 23
National Center for Advancing Translational Sciences (NCATS) 3 43
National Institute of Child Health and Human Development (NICHD) 2 43
National Human Genome Research Institute (NHGRI) 2 50
National Institute of Environmental Health Sciences (NIEHS) 1 26
National Center for Complementary and Integrative Health (NCCIH) 1 13
Centers for Disease Control and Prevention (CDC) 1 9
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) 1 1

Up to Start Of Table

Higher Education Research and Development (HERD)

FedInvent follows the HERD the Higher Education Research and Development institutions — the colleges and universities; research institutions, and medical schools that benefit from federal funding and rely on it to make important discoveries that drive American innovation. Taxpayer funded patents coming from mostly American and sometime foreign universities are an important indicia of the vitality of the American innovation ecosphere.

MEMBERS OF THE HERD

The National Science Foundation (NSF) Higher Education Research and Development (HERD) Survey is the primary source of information on R&D expenditures at 916 US colleges and universities that expended at least $150,000 in separately accounted for R&D in the fiscal year. We use the NSF list to keep track of which colleges and universities are receiving taxpayer-funded patents and filing patent applications.

WATCH This SPACE

We're working on our data analytics and will be reporting taxpayer-funded patents and patent applications shortly. In the meantime, FedInvent will post interesting information about the HERD Innovation Ecosphere here.

Top Ten Universities By R&D Expenditures
  1. Johns Hopkins University
  2. University of Michigan
  3. University of Washington
  4. University of California, San Diego
  5. University of California, San Francisco
  6. Columbia University in the City of New York
  7. Stanford University
  8. University Pittsburgh
  9. University Pennsylvania
  10. Duke University

Patent Applications by Scientific Domain.

This section contains the number of patents organiized by high level scientific and technical domain. The data is arranged by the first Cooperative Patent Classification System (CPC) patent symbol assigned to the patent. This indicates the scope and nature of the patented invention for a patent or a patent application.

Global patent offices use patent classification as their lingua franca — the common language — for exchanging information about inventions and what scientific and technical art a patent contains. The classifications assigned to a patent are used by patent examiners to find prior art and to determine if a particular patent's claims are novel. Patent classifications are also used for global enforcement of patent rights, treaties, and agreements.

Class Class Definition First
(Original)
Inventive
(CrossRef)
CPC A61 Medical or Veterinary Science; Hygiene 54 270
CPC C12 Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or Genetic Engineering 21 135
CPC C07 Organic Chemistry 21 95
CPC G01 Measuring; Testing 17 71
CPC B01 Physical or Chemical Processes or Apparatus in General 3 38
CPC H01 Basic Electric Elements 7 33
CPC C08 Organic Macromolecular Compounds; Their Preparation or Chemical Working-up; Compositions Based Thereon 3 35
CPC G06 Computing; Calculating; Counting 7 24
CPC A23 Foods or Foodstuffs; Treatment Thereof, Not Covered by Other Classes 2 24
CPC C04 Cements; Concrete; Artificial Stone; Ceramics; Refractories 1 16
CPC G02 Optics 5 11
CPC C01 Inorganic Chemistry 1 15
CPC H04 Electric Communication Technique 5 10
CPC A01 Agriculture; Forestry; Animal Husbandry; Hunting; Trapping; Fishing 2 10
CPC B64 Aircraft; Aviation; Cosmonautics 2 8
CPC D01 Edible products 0 10
CPC C25 Electrolytic or Electrophoretic Processes; Apparatus Therefor 2 6
CPC G05 Controlling; Regulating 2 6
CPC C02 Treatment of Water, Waste Water, Sewage, or Sludge 1 7
CPC C09 Dyes; Paints; Polishes; Natural Resins; Adhesives; Compositions Not Otherwise Provided For; Applications of Materials Not Otherwise Provided for 2 5
CPC B23 Machine Tools; Metal-working Not Otherwise Provided for 1 6
CPC G16 Information and Communication Technology [ICT] Specially Adapted for Specific Application Fields 1 6
CPC B25 Hand Tools; Portable Power-driven Tools; Manipulators 1 5
CPC B29 Working of Plastics; Working of Substances in a Plastic State in General 1 3
CPC G08 Signalling 1 3
CPC B09 Disposal of Solid Waste; Reclamation of Contaminated Soil 1 1
CPC H02 Generation; Conversion or Distribution of Electric Power 1 1
CPC H03 Basic Electronic Circuitry 1 1
CPC A62 Life-saving; Fire-fighting 1 0
CPC Y02 Technologies or Applications for Mitigation or Adaptation Against Climate Change 0 1

Up to Start Of Table

Count of Inventors by Country and U.S. State

Patent Applications by country and state based on location information of first named inventors and all listed inventors.

Country First Named Inventors All Inventors
United States of America 164 552
Germany 2 4
Macau 1 1
Israel 0 4
Italy 0 3
Russian Federation 0 3
Australia 0 2
United Kingdom 0 2
Sweden 0 2
Canada 0 1
Japan 0 1
Netherlands 0 1
U.S. State First Named Inventors All Inventors
California 34 101
Massachusetts 18 73
New York 11 42
Pennsylvania 10 35
Florida 9 25
Maryland 8 18
Texas 6 20
New Jersey 6 15
Washington 5 22
Virginia 5 18
Arizona 5 16
North Carolina 5 13
Illinois 5 12
Connecticut 4 13
Colorado 4 11
Wisconsin 4 11
Michigan 3 10
Ohio 3 9
Kansas 2 11
Missouri 2 11
Indiana 2 10
Tennessee 1 7
Mississippi 1 5
New Mexico 1 5
Minnesota 1 4
Alabama 1 3
Georgia 1 3
Kentucky 1 3
Utah 1 3
Nebraska 1 2
Wyoming 1 2
Idaho 1 1
District of Columbia 0 2
Oregon 0 2
Delaware 0 1
Rhode Island 0 1

Up to Start Of Table

Count of Assignees and Applicants by Country and U.S. State

Patent Applications by country and state based on location information of Assignees and Applicants.

Country Assignees Applicants
United States of America 60 208
Australia 0 1
Israel 0 1
Japan 0 1
Sweden 0 1
United Kingdom 0 1
U.S. State Assignees Applicants
Massachusetts 19 34
California 5 36
Maryland 4 10
Washington 4 6
Pennsylvania 3 11
Illinois 3 8
Texas 3 6
New Jersey 3 5
New York 2 15
District of Columbia 2 10
Florida 2 9
Indiana 2 4
Kansas 2 3
Arizona 1 8
North Carolina 1 6
Virginia 1 4
Wisconsin 1 4
Ohio 1 3
Georgia 1 2
Colorado 0 5
Connecticut 0 3
Minnesota 0 3
Missouri 0 3
Alabama 0 1
Idaho 0 1
Kentucky 0 1
Michigan 0 1
Nebraska 0 1
New Mexico 0 1
Oregon 0 1
Tennessee 0 1
Utah 0 1
Wyoming 0 1

Up to Start Of Table

Technology Center Explainer

How Tech Centers and Art Units Are Organized And Why It Matters

Patents travel from Technology Center to Art Unit to Group Art Unit to Patent Examiner.

The USPTO's patent corps is organized into Technology Centers (TCs), groups of patent examiners with specific scientific and technical domain expertise. Technology Centers are further divided into Art Units (AUs) organized by major types of inventive art within a scientific or technical domain. Art Units are organized into Group Art Units, even more specialized and granular teams of examiners.

Group Art Units (GAUs) are where patent examiners prosecute patent applications. Patent applications are docketed to examiners based on of specific subject matter classifications of a particular GAU.

Understanding Technology Centers, Art Units and Group Art Units helps you understand what type of inventions are being prosecuted within each scientific and technical domain, how long it takes from the date a patent application is filed to the time a final decision on the patentability of the invention is made.

Patents examined here cover:

Art Unit Technical & Scientific Domains
1610 Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
1620 Organic Chemistry
1630 Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
1640 Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
1650 Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzyme
1660 Plants

About Plant Patents

Plant Patents are granted by the Government to an inventor who has invented or discovered and asexually reproduced a distinct and new variety of plant, other than a tuber propagated plant or a plant found in an uncultivated state. If you've ever eaten a pluot, you've enjoyed the fruit of a plant patent.

Plant patent numbers begin with a "PP" followed by a five digit number. The first Plant Patent was issued in 1931. Plant patents are valid for 20 years from the filing date.

Patents examined here cover:

Art Unit Technical & Scientific Domains
1710 Coating, Etching, Cleaning, Single Crystal Growth
1720 Fuel Cells, Batteries, Solar Cells, Liquid Crystal Composition
1730 Metallurgy, Metal Working, Inorganic Chemistry, Catalysts, Electrophotography, Photolithography
1740 Tires, Adhesive Bonding, Glass/Paper making, Plastics Shaping & Molding
1760 Organic Chemistry, Polymers, Compositions
1770 Chemical Apparatus, Separation and Purification, Liquid and Gas Contact Apparatus
1780 Miscellaneous Articles, Stock Material, Adhesive Composition, Fabrics
1790 Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry

Patents examined here cover:

Art Unit Technical & Scientific Domains
2110 Coating, Etching, Cleaning, Single Crystal Growth
2120 Miscellaneous Articles, Stock Material, Adhesive Composition, Fabrics
2130 Fuel Cells, Batteries, Solar Cells, Liquid Crystal Composition
2140/2170 Metallurgy, Metal Working, Inorganic Chemistry, Catalysts, Electrophotography, Photolithography
2150/2160 Tires, Adhesive Bonding, Glass/Paper making, Plastics Shaping & Molding
2180 Organic Chemistry, Polymers, Compositions
2190 Chemical Apparatus, Separation and Purification, Liquid and Gas Contact Apparatus

Patents examined here cover:

Art Unit Technical & Scientific Domains
2410/2460/2470 Multiplex, VoIP
2420 Cable and Television
2430/2490 Cryptography and Security
2440/2450 Computer Networks
2480 Recording and Compression

Patents examined here cover:

Art Unit Technical & Scientific Domains
2610 Computer Graphic Processing, 3D Animation, Display Color Attribute, Object Processing, Hardware and Memory
2620 Selective Visual Display Systems
2630 Digital and Optical Communications
2640 Telecommunications: Analog Radio Telephone; Satellite and Power Control; Transceivers, Measuring and Testing; Bluetooth; Receivers and Transmitters; Equipment Details
2650 Videophones and Telephonic Communications; Audio Signals; Digital Audio Data Processing; Linguistics, Speech Processing and Audio Compression
2660 Digital Cameras; Image Analysis; Applications; pattern Recognition; Color and Compression; Enhancement and Transformation
2670 Facsimile; Printer; Color; halftone; Scanner; Computer Graphic Processing; 3-D Animation; Display Color; Attributes; Object Processing; Hardware and Memory
2680 Telemetry and Code Generation; Vehicles and System Alarms; Selective Communication; Dynamic Storage Systems; Mechanical parts of Disk Drives; Signal Processing and Control Processing in Disk Drives
2690 Selective Visual Display Systems

More broadly TC 2800 Art Units cover Semiconductors/Memory, Circuits/Measuring and Testing, Optics/Photocopying, Printing/Measuring and Testing.

Patents examined here cover:

Art Unit Technical & Scientific Domains
2810/2820/2890 Semiconductors/Memory
2830/2840 Electrical Circuits and Systems
2850/2860 Printing/Measuring and Testing
2870/2880 Optics

About Design Patents

The design FOR an article. Not to the design OF an article.

Patents examined here cover Design patents cover the appearance of an article. The design for an article consists of the visual characteristics embodied in or applied to an article. Since a design is manifested in appearance, the subject matter of a design patent application may relate to the configuration or shape of an article, to the surface ornamentation applied to an article, to the combination of configuration and surface ornamentation.

Design is inseparable from the article to which it is applied and cannot exist alone merely as a scheme of surface ornamentation. It must be a definite, preconceived thing, capable of reproduction and not merely the chance result of a method.

Design patent numbers begin with a "D" followed by a six-digit number. The first Design Patent was issued in 1843. The term of a design patent is 15 years measured from the date of grant if the design application was filed on or after May 13, 2015 (or 14 years if filed before May 13, 2015).

Patents examined here cover:

Art Unit Technical & Scientific Domains
3610 Surface Transportation
3620 Business Methods — Incentive Programs, Coupons; Operations Research; Electronic Shopping; Health Care; Point of Sale, Inventory, Accounting; Cost/Price, Reservations, Shipping and Transportation; Business Processing
3630 Static Structures, Supports and Furniture
3640 Aeronautics, Agriculture, Fishing, Trapping, Vermin Destroying, Plant and Animal Husbandry, Weaponry, Nuclear Systems, and License and Review
3650 Material and Article Handling
3660 Computerized Vehicle Controls and Navigation, Radio Wave, Optical and Acoustic Wave Communication, Robotics, and Nuclear Systems
3670 Wells, Earth Boring/Moving/Working, Excavating, Mining, Harvesters, Bridges, Roads, Petroleum, Closures, Connections, and Hardware
3680 Business Methods — Incentive Programs, Coupons; Electronic Shopping; Business Cryptography, Voting; Health Care; Point of Sale, Inventory, Accounting; Business Processing, Electronic Negotiation
3690 Business Methods — Finance/Banking/ Insurance

Patents examined here cover:

Art Unit Technical & Scientific Domains
3710 Amusement and Education Devices
3720 Manufacturing Devices and Processes, Machine Tools and Hand Tools
3730 Sheet Container Making, Package Making, Receptacles, Shoes, Apparel, and Tool Driving or Impacting
3740 Thermal and Combustion Technology, Motive and Fluid Power Systems
3750 Fluid Handling and Dispensing
3760 Refrigeration, Vaporization, Ventilation, and Combustion
3770 Medical & Surgical Instruments, Treatment Devices, Surgery and Surgical Supplies
3780 Body Treatment, Kinestherapy, and Exercising

FedInvent Patents

Each week FedInvent analyzes newly granted patents and published patent applications whose origins lead back to funding from the US federal government. We assemble a weekly patent catalog and analyze the inventions, the inventors, and the entities who received the patents. We map the patents back to the agency that funded the R&D that led to the new invention. FedInvent uses the funding opportunity descriptions, the grants, and the contracts that define the research areas of interest ,and the R&D policies and priorities of that drove and are driving the funding to organize each week's patents.

ABOUT OUR DATA

The weekly patent catalog includes patents with government interest statements indicating federal funding; and patents where the assignee, the owner of the invention, is the federal government. This includes work on federal grants, work on federal contracts, innovation by Federal Research and Development Centers (FFRDCs) funded by Federal Departments, and University Affiliated Research Centers funded by DoD.

Not every inventor is a government contractor. There are many inventions conceived and patented by scientists and engineers working for the federal government or serving in the military.

THE NUMBERS MAY NOT MATCH THE NUMBER OF PATENTS WE ANALYZE EACH WEEK

The numbers in the tables presented on this page will not add up to the number of patents granted each week because patents are counted by each agency that funded the creation of the invention. Patents and funding have a many-to-many relationship. One patent may have more than one funding grant or contract associated with it. A grant or contract may lead to more than one patent. More than one agency may have funded the inventors or the contract. More than one university or business may have worked together on an invention. When we report the numbers here, we associate a patent with all of the entities and funding that are reflected on the patent and report them to you. This approach presents a more complete picture of what's going on in the federal innovation ecosphere. Put another way, the numbers in the tables presented on this page may not always add up to the number of patents each week because patents are counted by each agency that funded the creation of the invention.

Subscribe to The FedInvent™ Newsletter

 The latest from FedInvent delivered right to your inbox.